Found: 103
Select item for more details and to access through your institution.
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00868-w
- By:
- Publication type:
- Article
Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 92, doi. 10.1093/jjco/hyy177
- By:
- Publication type:
- Article
Somatic mutations of EGFR, ERBB2, ERBB3 and ERBB4 in juxtamembrane activating domains are rare in non-small cell lung cancers.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Analysis of NOTCH1 extracellular juxtamembrane expansion mutations in acute leukemias and multiple myelomas.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Development of an Automated Image Analyzer for Microvessel Density Measurement in Bone Marrow Biopsies.
- Published in:
- Annals of Laboratory Medicine, 2020, v. 40, n. 4, p. 312, doi. 10.3343/alm.2020.40.4.312
- By:
- Publication type:
- Article
T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia.
- Published in:
- Annals of Laboratory Medicine, 2019, v. 39, n. 2, p. 125, doi. 10.3343/alm.2019.39.2.125
- By:
- Publication type:
- Article
Clinical Implications of Quantitative JAK2 V617F Analysis using Droplet Digital PCR in Myeloproliferative Neoplasms.
- Published in:
- Annals of Laboratory Medicine, 2018, v. 38, n. 2, p. 147, doi. 10.3343/alm.2018.38.2.147
- By:
- Publication type:
- Article
Comparison of Two Apheresis Systems of COBE and Optia for Autologous Peripheral Blood Stem Cell Collection.
- Published in:
- Annals of Laboratory Medicine, 2017, v. 37, n. 4, p. 327, doi. 10.3343/alm.2017.37.4.327
- By:
- Publication type:
- Article
Somatic mutation of PIK3R1 gene is rare in common human cancers.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Somatic mutation of GNAQ gene is rare in common solid cancers and leukemias.
- Published in:
- Acta Oncologica, 2009, v. 48, n. 7, p. 1082, doi. 10.1080/02841860902882444
- By:
- Publication type:
- Article
Absence of oncogenic AKT1 E17K mutation in prostate, esophageal, laryngeal and urothelial carcinomas, hepatoblastomas, gastrointestinal stromal tumors and malignant meningiomas.
- Published in:
- Acta Oncologica, 2009, v. 48, n. 7, p. 1084, doi. 10.1080/02841860902878152
- By:
- Publication type:
- Article
Reference intervals for circulating angiogenic cytokines.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2008, v. 46, n. 4, p. 545, doi. 10.1515/CCLM.2008.092
- By:
- Publication type:
- Article
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin.
- Published in:
- Journal of Pathology, 2010, v. 220, n. 4, p. 446, doi. 10.1002/path.2653
- By:
- Publication type:
- Article
4-1BB immunotherapy: advances and hurdles.
- Published in:
- Experimental & Molecular Medicine EMM, 2024, v. 56, n. 1, p. 32, doi. 10.1038/s12276-023-01136-4
- By:
- Publication type:
- Article
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 877, doi. 10.1007/s10637-018-0582-0
- By:
- Publication type:
- Article
Analysis of laboratory parameters for optimal autologous peripheral blood stem cell collection from lymphoma and myeloma patients.
- Published in:
- Journal of Clinical Apheresis, 2021, v. 36, n. 1, p. 135, doi. 10.1002/jca.21855
- By:
- Publication type:
- Article
Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection.
- Published in:
- Journal of Clinical Apheresis, 2021, v. 36, n. 1, p. 28, doi. 10.1002/jca.21835
- By:
- Publication type:
- Article
Secondary Malignancies in Multiple Myeloma in Korean Patients: A Nationwide Population-Based Study.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 936, doi. 10.4143/crt.2023.843
- By:
- Publication type:
- Article
Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1355, doi. 10.4143/crt.2023.271
- By:
- Publication type:
- Article
Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 693, doi. 10.4143/crt.2022.952
- By:
- Publication type:
- Article
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 684, doi. 10.4143/crt.2022.1434
- By:
- Publication type:
- Article
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 325, doi. 10.4143/crt.2022.008
- By:
- Publication type:
- Article
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1268, doi. 10.4143/crt.2021.1168
- By:
- Publication type:
- Article
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30--Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 2, p. 374, doi. 10.4143/crt.2019.198
- By:
- Publication type:
- Article
Nationwide Statistical Analysis of Lymphoid Malignancies in Korea.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 1, p. 222, doi. 10.4143/crt.2017.093
- By:
- Publication type:
- Article
Trends in multiple myeloma incidence, prevalence, mortality, and survival rate in South Korea: a nationwide population-based study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 10, p. 4111, doi. 10.1007/s00277-024-05701-3
- By:
- Publication type:
- Article
Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 7, p. 2365, doi. 10.1007/s00277-024-05615-0
- By:
- Publication type:
- Article
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 1989, doi. 10.1007/s00277-023-05603-w
- By:
- Publication type:
- Article
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2233, doi. 10.1007/s00277-023-05308-0
- By:
- Publication type:
- Article
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2051, doi. 10.1007/s00277-021-04407-0
- By:
- Publication type:
- Article
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 11, p. 1895, doi. 10.1007/s00277-014-2137-6
- By:
- Publication type:
- Article
Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 8, p. 1353, doi. 10.1007/s00277-014-2057-5
- By:
- Publication type:
- Article
Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 113, doi. 10.1007/s00277-013-1893-z
- By:
- Publication type:
- Article
Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 4, p. 543, doi. 10.1007/s00277-011-1337-6
- By:
- Publication type:
- Article
Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL).
- Published in:
- Annals of Hematology, 2012, v. 91, n. 2, p. 223, doi. 10.1007/s00277-011-1297-x
- By:
- Publication type:
- Article
Comparative analysis of single versus tandem autologous stem cell transplantation in patients with multiple myeloma in Korea: the KMM2102 study.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-74625-9
- By:
- Publication type:
- Article
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2192, doi. 10.3390/cancers12082192
- By:
- Publication type:
- Article
A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1514, doi. 10.1007/s10637-013-0015-z
- By:
- Publication type:
- Article
Adenovirus Expressing Both Thymidine Kinase and Soluble PD1 Enhances Antitumor Immunity by Strengthening CD8 T-cell Response.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 3, p. 688, doi. 10.1038/mt.2012.252
- By:
- Publication type:
- Article
Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 100, doi. 10.1002/cam4.970
- By:
- Publication type:
- Article
Radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma: dose-volumetric analysis and its clinical implications.
- Published in:
- Radiation Oncology Journal, 2016, v. 34, n. 3, p. 193, doi. 10.3857/roj.2016.01865
- By:
- Publication type:
- Article
Retrospective Comparison of Bortezomib-containing Regimens with Vincristine–Doxorubicin–Dexamethasone (VAD) as Induction Treatment Prior to Autologous Stem Cell Transplantation for Multiple Myeloma.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 7, p. 449, doi. 10.1093/jjco/hyp046
- By:
- Publication type:
- Article